European Commission Grants Approval for CASGEVY™ for Treatment of Sickle Cell Disease and Beta-Thalassemia

European Commission Grants Approval for CASGEVY™ for Treatment of Sickle Cell Disease and Beta-Thalassemia

13 February 2024
European Commission Grants Approval for CASGEVY™ for Treatment of Sickle Cell Disease and Beta-Thalassemia
The European Commission has granted conditional marketing authorization for CASGEVY.
Read More
European Commission Grants Approval for CASGEVY™ for Treatment of Sickle Cell Disease and Beta-Thalassemia
13 February 2024
European Commission Grants Approval for CASGEVY™ for Treatment of Sickle Cell Disease and Beta-Thalassemia
The European Commission has granted
Kite Receives FDA Approval for Manufacturing Process Change for Yescarta
1 February 2024
Kite Receives FDA Approval for Manufacturing Process Change for Yescarta
Kite Receives FDA Approval for
Gene Therapy Pioneer Dr Luigi Naldini Receives Prestigious Lifetime Achievement Award
18 January 2024
Gene Therapy Pioneer Dr Luigi Naldini Receives Prestigious Lifetime Achievement Award
The award was presented by
Cellply Launches VivaCyte, its End-to-End Single Cell Potency Characterization Platform
18 January 2024
Cellply Launches VivaCyte, its End-to-End Single Cell Potency Characterization Platform
Cellply has launched its end-to-end
POPULAR NEWS ITEMS
Image
14 May 2024

Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing

Image
8 April 2024

Women in Advanced Therapies Global 2024, Virtual Event

Image
25 March 2024

RNA Connect 2025, South Carolina

Charles River Launches Off-the-Shelf Rep/Cap to Simplify Gene Therapy Supply Chains
17 January 2024
Charles River Launches Off-the-Shelf Rep/Cap to Simplify Gene Therapy Supply Chains
Charles River launches off-the-shelf Rep/Cap
TrakCel launches Consultancy Services to Share Extensive Cell and Gene Therapy Process Development Expertise
16 January 2024
TrakCel launches Consultancy Services to Share Extensive Cell and Gene Therapy Process Development Expertise
TrakCel has introduced Consultancy Services
Load More News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Gene Editing
Industry Insights
Manufacturing
Patient Access & Engagement
Regulatory & Standards
Cell Therapy
Characterisation
ATW
Gene Therapy
GMP
Viral/Non-Viral Vectors
Automation & Digitisation
CAR-X
Strategy
Autologous
Finance & Investment
Raw Materials
Scaling Up
Techniques
Partnering
Cell-Based IO
Events – ATW
Tissue Engineering
Stem Cells
Events
Allogeneic
Reimbursement
NKx
Skills, Talent & Development
Supply Chain
CMC
Logistics
Point of Care
Uncategorized
POPULAR NEWS ITEMS
Image

Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing

Image

Learning From Experience: Navigating Cell & Gene Therapy Development Challenges with Productive CDMO Partnerships

Image

Partnering to Enable Solutions for Allogeneic Cell Therapy Industrialization